4613347880

Flood, E.A., McKenzie, M.O., and Lyles, D.S. (2000). Role of M Protein aggregation m defective assembly of temperature-sensitive M protein mutants of Vesicular Stomatitis Virus. Virology 278, 520-533.

Fosbrink, M., Cudrici, C., Niculescu, F., Badea, T.C., David, S., Shamsuddin, A., Shin, M.L., and Rus, H. (2005). Overexpression of RGC-32 in colon cancer and other tumors. Exp. Mol. Pathol. 78, 116-122.

Franco, O.E., and Hayward, S.W. (2012). Chapter Ninę - Targeting the tumor stroma as anovel therapeutic approach for prostatę cancer. In Adv. Pharmacol., S.M.S. Keiran, ed. (Academic Press), pp. 267-313.

Francoeur, A.M., Lam, T., and Stanners, C.P. (1980). PIF, a highly sensitive plaque assay for the induction of interferon. Virology 105, 526-536.

Francoeur, A.M., Poliąuin, L., and Stanners, C.P. (1987). The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis. Virology 160, 236-245.

Francoz, S., Mathiaux, J., and Dubus, P. (2012). Modeles precliniques chez le rongeur de carcinomes pulmonaires. Buli. Cancer (Paris) 99, 1017-1027.

Frank, A., Pimkina, J., and Murphy, M.E. (2012). Tumor suppressor genes. In Cancer The outlaw celi, R.E. LaFond, ed. (New York: Oxford University Press).

Frank, M.M., and Fries, L.F. (1991). The role of complement in inflammation and phagocytosis. Immunol. Today 12, 322-326.

Fritzinger, D.C., Hew, B.E., Thome, M., Pangbum, M.K., Janssen, B.J.C., Gros, P., and Vogel, C.-W. (2009). Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion. Developmental & Comparative Immunology 33, 105-116.

Fu, X., and Zhang, X. (2002). Potent systemie antitumor activity from an oncolytic Herpes Simplex Virus of syncytial phenotype. Cancer Res. 62, 2306-2312.

Fueyo, J., Gomez-Manzano, C., Alemany, R., Lee, P.S., McDonnell, T.J., Mitlianga, P., Shi, Y.-X., Levin, V., Yung, A.W., and Kyritsis, A.P. (2000). A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 19, 2-12.